Subsequently, however, it became clear that MLLr cancers are not dependent on MLL1, but instead rely on MLL2 [91]—notable in this case because, although MLL2 complexes with WDR5, it does not depend on Win site binding for methyltransferase activity [33]. The gene discussed is KMT2A; the disease is cancer.